Author:
Tashkin Donald P.,Hanania Nicola A.,McGinty Joe,Denis-Mize Kimberly,Chaudry Imtiaz
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference34 articles.
1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2008 Update. National Institutes of Health/WHO. Available at: http://www.goldcopd.org . Accessed January 5, 2009.
2. Dahl R, Greefhorst LAPM, Nowak D, et al. Inhaled formoterol; dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:778–784.
3. Aalbers R, Ayres J, Backer V, et al. Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. Eur Respir J. 2002;19:936–943.
4. Gross NJ, Nelson HS, Lapidus RJ, et al. Efficacy and safety of formoterol fumurate delivered by nebulization to COPD patients. Respir Med. 2008;102:189–197.
5. Cardiovascular safety of nebulized formoterol: results of a placebo-controlled, double-blind phase III study. Clin Ther. 2007;29:2167–2178.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献